My Med 
Pill 
Drug Interaction 
Drugs & 
Symptom 
Side 
Conditions 
Treatment 
Compare 
Discount 
FDA 
Price 
Phonetic 
Health Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA Approves Hibsago (bepirovirsen) for the Treatment of Chronic Hepatitis B
20 October 2026 -- GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Hibsago (bepirovirsen) for...
Cosette Pharmaceuticals Announces FDA Approval of Evoxac (cevimeline HCl) Oral Solution
(BUSINESS WIRE) October 20, 2026 --Cosette Pharmaceuticals, Inc. (“Cosette”), a U.S.-based specialty pharmaceutical company, today announced...
Jemperli (dostarlimab-gxly) Approved in US as First and Only Immunotherapy for Adults with MSI-H/dMMR Locally Advanced Rectal Cancer
October 19 2026 -- GSK plc (LSE/NYSE: GSK) today announced the US Food and Drug Administration (FDA) has approved Jemperli (dostarlimab-gxly) as the...
FDA Approves Genentech’s Enspryng, a First-in-Class IL-6R Inhibitor, as the First and Only At-Home Subcutaneous Treatment Option for Thyroid Eye Disease (TED)
October 15, 2026 -- Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA)...
FDA Approves Brytly (apraclonidine) Ophthalmic Solution for Relief of Eye Redness
(BUSINESS WIRE) October 16, 2026 -- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that...
HbA1c, Weight Increases Seen After Antipsychotic Initiation
Antipsychotic treatment initiation is associated with rapid increases in hemoglobin A1c (HbA1c) and weight, according to a study published in the November...
Some Benefits Found for GLP-1 Receptor Agonists in Older Adults With MASLD
For older adults with metabolic dysfunction-associated steatotic liver disease (MASLD), glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment is...
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate New Drug Application Resubmission and PDUFA Date of March 25, 2027
Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies...
Recommendations Updated for Management of Tinnitus
Updated recommendations are presented for the management of tinnitus in a clinical practice guideline issued by the American Academy of Otolaryngology-Head...
CGM Beneficial for Adults With Type 2 Diabetes Not on Insulin
Continuous glucose monitoring (CGM) leads to a greater reduction in glycated hemoglobin (HbA1c) levels than routine care for adults with type 2 diabetes...
First Generic Combo Hormone Patch Could Make Menopause Relief More Affordable
WEDNESDAY, Oct. 21, 2026 — Women looking for relief from menopause symptoms could soon have a more affordable option for a weekly hormone patch. The...
Menopause And Exercise: Experts Share What Works
WEDNESDAY, Oct. 21, 2026 — Hot flashes and night sweats tend to dominate conversations about menopause, but some of the most important changes are...
FDA Patient, Consumer Reps Often Tied To Pharma-Funded Groups
WEDNESDAY, Oct. 21, 2026 — Patient and consumer representatives advising U.S. Food and Drug Administration (FDA) expert panels might actually be...
Is There A Hidden Link Between Migraine And Endometriosis?
WEDNESDAY, Oct. 21, 2026 — Up to 3 out of 4 women with endometriosis may also suffer from migraines. But new research suggests that overlap is often...
Novo’s CagriSema Was Associated with 25% Weight Loss on Average for Women in a Post Hoc Analysis of REDEFINE 1
PLAINSBORO, N.J. and BAGSVÆRD, Denmark, Oct. 20, 2026 /PRNewswire/ -- Today, Novo announced results from two post hoc analyses of the...
XBiotech Announces Positive Phase II Final Efficacy Results from Investigator-Sponsored TASKIN Trial of Vilamakitug in Refractory Metastatic Colorectal Cancer
XBiotech Inc. (NASDAQ: XBIT) today announced positive final efficacy results from the randomized Phase II portion of the multicenter TASKIN clinical trial....
5 At-Home Strength Moves That Can Make Everyday Tasks Easier
MONDAY, Oct. 19, 2026 — If you’ve ever needed two trips to get the groceries in from the car or felt winded after a flight of stairs, you’ve...
Counterfeit Versions of Eye Drops Found in Several States
Counterfeit versions of over-the-counter eye drops have been found in Florida and Georgia in stores serving primarily Spanish-speaking customers. These...
Aquestive Therapeutics Announces FDA Acceptance of Anaphylm NDA Resubmission
Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a biopharmaceutical company advancing medicines to...
Recently Added
Recently added consumer and prescribing information: Lamlique, Weltruza, Hovilpri, Emcitate, Atebrioz, Onswik, Juvmo, Isembyld, Etcamah, Bixlenvo
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex CareNotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Hibsago Hibsago (bepirovirsen) is a hepatitis B virus (HBV) mRNA-directed antisense oligonucleotide (ASO) for use in the treatment of chronic HBV...
- Brytly Brytly (apraclonidine hydrochloride) is a nonprescription alpha adrenergic agonist ophthalmic solution for the relief of redness of the eye...
- Hovilpri Hovilpri (pritelivir) is a helicase-primase inhibitor for the treatment of mucocutaneous lesions caused by herpes simplex virus (HSV) infection.
Drug Information
Tools
- Interaction Checker
- Pill Identifier
- Symptom Checker
- Medication Record
- Mobile Apps
- Drug Imprint Codes
- Community Support
- Compare Drugs
News & Alerts
- Medical News
- Clinical Trial Results
- FDA Drug Alerts
- FDA Consumer Updates
- New FDA Approvals
- New Drug Applications
- Drug Shortages
- Video Center
- Popular Articles
Professionals
Top 100 Drugs
- Abilify
- Adderall
- Aimovig
- Ambien
- Atorvastatin
- Austedo
- Avastin
- Benlysta
- Biktarvy
- Botox
- Breztri
- Buprenorphine
- Cabenuva
- Cimzia
- Cosentyx
- Diazepam
- Descovy
- Diclofenac
- Doxycycline
- Duloxetine
- Dupixent
- Emgality
- Enhertu
- Entyvio
- Epclusa
- Erleada
- Evenity
- Fasenra
- Farxiga
- Gabapentin
- Gemtesa
- Humira
- Ibuprofen
- Imbruvica
- Januvia
- Jardiance
- Kesimpta
- Keytruda
- Kisqali
- Leqembi
- Leqvio
- Lexapro
- Lybalvi
- Lyrica
- Metformin
- Methadone
- Methotrexate
- Mounjaro
- Naloxone
- Naltrexone
- Nucala
- Nurtec
- Ofev
- Opdivo
- Orladeyo
- Otezla
- Oxycodone
- Ozempic
- Paxlovid
- Penicillin
- Praluent
- Prednisone
- Prozac
- Qulipta
- Quviviq
- Reblozyl
- Repatha
- Restasis
- Rexulti
- Rybelsus
- Semaglutide
- Seroquel
- Sildenafil
- Skyrizi
- Sotyktu
- Stelara
- Sublocade
- Taltz
- Tepezza
- Tramadol
- Tremfya
- Trintellix
- Tylenol
- Ubrelvy
- Vabysmo
- Venclexta
- Verzenio
- Viagra
- Vijoice
- Vraylar
- Vumerity
- Vyepti
- Vyvanse
- Vyvgart
- Wegovy
- Wellbutrin
- Xanax
- Xolair
- Xyrem
- Zepbound
